Share Price and Basic Stock Data
Last Updated: January 29, 2026, 7:34 pm
| PEG Ratio | 1.08 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Checkpoint Trends Ltd, operating in the pharmaceuticals sector, reported a current share price of ₹126 and a market capitalization of ₹69.1 Cr. The company has experienced fluctuating sales over the past few quarters. Sales were ₹0.36 Cr in September 2022, declining to ₹0.08 Cr by March 2023, before rebounding to ₹0.29 Cr in September 2023. Notably, the trailing twelve months (TTM) sales stood at ₹121 Cr, indicating potential growth momentum. The company has reported a significant increase in sales projected for FY 2025, particularly with a remarkable spike to ₹108.59 Cr in September 2025. Despite these fluctuations, the overall revenue trajectory shows signs of recovery, suggesting that Checkpoint Trends is navigating through a challenging market environment and is poised for future growth.
Profitability and Efficiency Metrics
Checkpoint Trends Ltd’s profitability remains a focal point of concern, with an operating profit margin (OPM) of just 1.66%. The OPM reflected considerable volatility, reaching a peak of 89.66% in September 2023 but fluctuating significantly throughout the quarters. The net profit stood at ₹1 Cr with an earnings per share (EPS) of ₹0.04 for FY 2025, demonstrating a slight recovery from previous losses. The return on equity (ROE) was reported at 9.17%, while the return on capital employed (ROCE) was significantly higher at 16.5%, indicating effective utilization of capital. The cash conversion cycle has lengthened, currently at 211.70 days, which may indicate challenges in cash flow management. The company’s interest coverage ratio, remarkably high at 111.40x, suggests a strong ability to meet interest obligations, although the overall profitability metrics warrant cautious evaluation.
Balance Sheet Strength and Financial Ratios
The balance sheet of Checkpoint Trends reflects a precarious financial position, primarily characterized by negative reserves of ₹4 Cr and no borrowings, which indicates a zero-debt status. The company’s book value per share was reported at ₹1.02, while the price-to-book value ratio stood at 12.54x, suggesting that the stock may be overvalued relative to its book value. The current ratio is notably high at 6.92, indicating strong liquidity and the ability to cover short-term liabilities. However, the absence of reserves and the declining trend in assets and liabilities raises questions about the sustainability of operations. The company’s financial ratios, including an interest coverage ratio of 111.40%, highlight its capacity to handle its financial obligations, which is a strength amidst the otherwise concerning balance sheet metrics.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Checkpoint Trends Ltd indicates a significant shift, with public shareholders holding 89.14% of the company as of March 2025, while foreign institutional investors (FIIs) accounted for 10.86%. This marks a noteworthy increase from a previous period where FIIs held no stake. The number of shareholders has grown to 2,416, reflecting increased retail interest and potential investor confidence. However, the lack of promoter holding raises concerns about the commitment of foundational stakeholders to the company’s long-term vision. The steady rise in public participation may indicate a growing interest in the company’s future prospects, especially given the recent sales recovery; however, the absence of institutional backing could hinder broader market acceptance and stability.
Outlook, Risks, and Final Insight
Looking ahead, Checkpoint Trends Ltd appears to be at a critical juncture. The projected sales surge in FY 2025 positions the company for potential growth, yet several risks loom. The high cash conversion cycle poses a liquidity risk, and the reliance on fluctuating sales could impact profitability. Additionally, the negative reserves signal underlying financial distress that could affect operational stability. However, the strong interest coverage ratio and the absence of debt provide a buffer against short-term financial pressures. Overall, while strengths such as liquidity and a rising shareholder base offer a foundation for growth, the company must address its profitability challenges and maintain operational efficiency to ensure sustainable progress in a competitive pharmaceuticals landscape. The future trajectory will depend on strategic management of cash flows and operational efficiencies to capitalize on emerging market opportunities.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Lactose (India) Ltd | 123 Cr. | 97.4 | 197/84.3 | 27.1 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.29/1.68 | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 3,370 Cr. | 310 | 479/192 | 69.8 | 24.3 | 0.22 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 33.0 Cr. | 44.5 | 82.8/37.2 | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 69.7 Cr. | 47.6 | 47.6/17.0 | 166 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Industry Average | 19,391.12 Cr | 1,073.18 | 47.27 | 202.32 | 0.38% | 16.29% | 15.20% | 6.10 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.36 | 0.21 | 0.08 | 0.20 | 0.29 | 0.17 | 0.47 | 0.10 | 0.05 | 0.10 | 0.25 | 11.71 | 108.59 |
| Expenses | 0.35 | 0.21 | 0.19 | 0.25 | 0.03 | 0.11 | 0.71 | 0.07 | 0.08 | 0.14 | 0.16 | 11.62 | 106.79 |
| Operating Profit | 0.01 | 0.00 | -0.11 | -0.05 | 0.26 | 0.06 | -0.24 | 0.03 | -0.03 | -0.04 | 0.09 | 0.09 | 1.80 |
| OPM % | 2.78% | 0.00% | -137.50% | -25.00% | 89.66% | 35.29% | -51.06% | 30.00% | -60.00% | -40.00% | 36.00% | 0.77% | 1.66% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | -0.02 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.01 | 0.00 | -0.11 | -0.05 | 0.26 | 0.06 | -0.24 | 0.03 | -0.03 | -0.02 | 0.07 | 0.09 | 1.80 |
| Tax % | 0.00% | -9.09% | 0.00% | 0.00% | 0.00% | -4.17% | 0.00% | 33.33% | 0.00% | 0.00% | 0.00% | 26.11% | |
| Net Profit | 0.01 | 0.00 | -0.10 | -0.05 | 0.26 | 0.06 | -0.23 | 0.02 | -0.04 | -0.02 | 0.06 | 0.09 | 1.32 |
| EPS in Rs | 0.02 | 0.00 | -0.18 | -0.09 | 0.48 | 0.11 | -0.42 | 0.04 | -0.07 | -0.04 | 0.11 | 0.16 | 2.41 |
Last Updated: January 9, 2026, 2:47 am
Below is a detailed analysis of the quarterly data for Checkpoint Trends Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 108.59 Cr.. The value appears strong and on an upward trend. It has increased from 11.71 Cr. (Jun 2025) to 108.59 Cr., marking an increase of 96.88 Cr..
- For Expenses, as of Sep 2025, the value is 106.79 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.62 Cr. (Jun 2025) to 106.79 Cr., marking an increase of 95.17 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.80 Cr.. The value appears strong and on an upward trend. It has increased from 0.09 Cr. (Jun 2025) to 1.80 Cr., marking an increase of 1.71 Cr..
- For OPM %, as of Sep 2025, the value is 1.66%. The value appears strong and on an upward trend. It has increased from 0.77% (Jun 2025) to 1.66%, marking an increase of 0.89%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.80 Cr.. The value appears strong and on an upward trend. It has increased from 0.09 Cr. (Jun 2025) to 1.80 Cr., marking an increase of 1.71 Cr..
- For Tax %, as of Sep 2025, the value is 26.11%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Jun 2025) to 26.11%, marking an increase of 26.11%.
- For Net Profit, as of Sep 2025, the value is 1.32 Cr.. The value appears strong and on an upward trend. It has increased from 0.09 Cr. (Jun 2025) to 1.32 Cr., marking an increase of 1.23 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.41. The value appears strong and on an upward trend. It has increased from 0.16 (Jun 2025) to 2.41, marking an increase of 2.25.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:59 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 121 |
| Expenses | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 119 |
| Operating Profit | -0 | -0 | -0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 2 |
| OPM % | -5% | 10% | -1% | -31% | 2% | 2% | -1% | -7% | 3% | 20% | 2% | ||
| Other Income | 0 | -3 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0 | -3 | -0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 2 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 20% | 0% | 50% | 0% | -50% | 40% | |
| Net Profit | -0 | -3 | -0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 1 |
| EPS in Rs | -0.11 | -5.61 | -0.02 | 0.05 | -0.29 | -0.02 | 0.05 | 0.02 | -0.07 | -0.15 | 0.05 | 0.05 | 2.64 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 |
|---|---|
| YoY Net Profit Growth (%) | 100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% |
Checkpoint Trends Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 1 years from 2015-2016 to 2015-2016.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -13% |
| 3 Years: | -37% |
| TTM: | 1076% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 25% |
| 3 Years: | 40% |
| TTM: | -18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 79% |
| 3 Years: | 128% |
| 1 Year: | 328% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -2% |
| 3 Years: | -1% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 2:56 pm
Balance Sheet
Last Updated: December 4, 2025, 2:37 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | -2 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -4 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 139 |
| Total Liabilities | 4 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 141 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 4 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 141 |
| Total Assets | 4 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 141 |
Below is a detailed analysis of the balance sheet data for Checkpoint Trends Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Reserves, as of Sep 2025, the value is -4.00 Cr.. The value appears to be improving (becoming less negative). It has improved from -5.00 Cr. (Mar 2025) to -4.00 Cr., marking an improvement of 1.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. However, Reserves are negative, which is a major warning sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 139.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Mar 2025) to 139.00 Cr., marking an increase of 139.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 141.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 141.00 Cr., marking an increase of 140.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 141.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 141.00 Cr., marking an increase of 140.00 Cr..
- For Total Assets, as of Sep 2025, the value is 141.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 141.00 Cr., marking an increase of 140.00 Cr..
However, the Borrowings (0.00 Cr.) are higher than the Reserves (-4.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36.50 | 23.55 | 53.96 | 179.41 | 106.92 | 163.88 | 121.67 | 135.30 | 229.34 | 211.70 | ||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 36.50 | 23.55 | 53.96 | 179.41 | 106.92 | 163.88 | 121.67 | 135.30 | 229.34 | 211.70 | ||
| Working Capital Days | 18.25 | -35.32 | 36.50 | 259.83 | 221.21 | 59.59 | 98.06 | 129.01 | 145.35 | 386.90 | ||
| ROCE % | -1.62% | -3.42% | -2.56% | 7.41% | 25.49% | -30.51% | 3.33% | 1.61% | -3.31% | -12.80% | 3.36% | 16.51% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.05 | 0.06 | -0.14 | -0.07 | 0.01 |
| Diluted EPS (Rs.) | 0.05 | 0.06 | -0.14 | -0.07 | 0.01 |
| Cash EPS (Rs.) | 0.06 | 0.06 | -0.13 | -0.06 | 0.01 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.02 | 0.97 | 0.30 | 1.06 | 1.13 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.02 | 0.97 | 0.30 | 1.06 | 1.13 |
| Revenue From Operations / Share (Rs.) | 0.91 | 2.07 | 2.12 | 3.68 | 0.88 |
| PBDIT / Share (Rs.) | 0.10 | 0.05 | -0.14 | -0.03 | 0.01 |
| PBIT / Share (Rs.) | 0.08 | 0.04 | -0.14 | -0.04 | 0.01 |
| PBT / Share (Rs.) | 0.08 | 0.04 | -0.14 | -0.04 | 0.01 |
| Net Profit / Share (Rs.) | 0.04 | 0.05 | -0.14 | -0.06 | 0.01 |
| PBDIT Margin (%) | 11.14 | 2.62 | -6.69 | -1.02 | 2.06 |
| PBIT Margin (%) | 9.58 | 2.00 | -6.94 | -1.10 | 1.73 |
| PBT Margin (%) | 9.48 | 1.98 | -6.95 | -1.10 | 1.67 |
| Net Profit Margin (%) | 5.08 | 2.67 | -6.77 | -1.81 | 1.15 |
| Return on Networth / Equity (%) | 4.55 | 5.67 | -47.59 | -6.28 | 0.90 |
| Return on Capital Employeed (%) | 8.58 | 4.25 | -16.02 | -3.81 | 1.35 |
| Return On Assets (%) | 3.89 | 3.23 | -11.91 | -4.31 | 0.62 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.89 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.63 | 1.42 | 1.54 | 2.30 | 0.58 |
| Current Ratio (X) | 6.92 | 2.14 | 3.83 | 3.15 | 3.11 |
| Quick Ratio (X) | 6.92 | 2.14 | 3.83 | 3.15 | 3.11 |
| Interest Coverage Ratio (X) | 111.40 | 128.60 | -1171.97 | -181.21 | 37.21 |
| Interest Coverage Ratio (Post Tax) (X) | 51.80 | 131.77 | -1183.78 | -320.75 | 21.89 |
| Enterprise Value (Cr.) | 6.97 | 5.39 | 2.70 | 1.60 | 0.81 |
| EV / Net Operating Revenue (X) | 13.94 | 4.77 | 2.33 | 0.79 | 1.66 |
| EV / EBITDA (X) | 125.12 | 181.40 | -34.73 | -77.64 | 80.74 |
| MarketCap / Net Operating Revenue (X) | 13.99 | 4.78 | 2.22 | 0.80 | 2.73 |
| Price / BV (X) | 12.54 | 10.14 | 15.68 | 2.78 | 2.14 |
| Price / Net Operating Revenue (X) | 13.99 | 4.78 | 2.23 | 0.80 | 2.73 |
| EarningsYield | 0.00 | 0.01 | -0.03 | -0.02 | 0.00 |
After reviewing the key financial ratios for Checkpoint Trends Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 0.06.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.02. It has increased from 0.97 (Mar 24) to 1.02, marking an increase of 0.05.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.02. It has increased from 0.97 (Mar 24) to 1.02, marking an increase of 0.05.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.91. It has decreased from 2.07 (Mar 24) to 0.91, marking a decrease of 1.16.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 2. It has increased from 0.05 (Mar 24) to 0.10, marking an increase of 0.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.08. This value is within the healthy range. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.08. This value is within the healthy range. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 2. It has decreased from 0.05 (Mar 24) to 0.04, marking a decrease of 0.01.
- For PBDIT Margin (%), as of Mar 25, the value is 11.14. This value is within the healthy range. It has increased from 2.62 (Mar 24) to 11.14, marking an increase of 8.52.
- For PBIT Margin (%), as of Mar 25, the value is 9.58. This value is below the healthy minimum of 10. It has increased from 2.00 (Mar 24) to 9.58, marking an increase of 7.58.
- For PBT Margin (%), as of Mar 25, the value is 9.48. This value is below the healthy minimum of 10. It has increased from 1.98 (Mar 24) to 9.48, marking an increase of 7.50.
- For Net Profit Margin (%), as of Mar 25, the value is 5.08. This value is within the healthy range. It has increased from 2.67 (Mar 24) to 5.08, marking an increase of 2.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is 4.55. This value is below the healthy minimum of 15. It has decreased from 5.67 (Mar 24) to 4.55, marking a decrease of 1.12.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.58. This value is below the healthy minimum of 10. It has increased from 4.25 (Mar 24) to 8.58, marking an increase of 4.33.
- For Return On Assets (%), as of Mar 25, the value is 3.89. This value is below the healthy minimum of 5. It has increased from 3.23 (Mar 24) to 3.89, marking an increase of 0.66.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has decreased from 1.42 (Mar 24) to 0.63, marking a decrease of 0.79.
- For Current Ratio (X), as of Mar 25, the value is 6.92. This value exceeds the healthy maximum of 3. It has increased from 2.14 (Mar 24) to 6.92, marking an increase of 4.78.
- For Quick Ratio (X), as of Mar 25, the value is 6.92. This value exceeds the healthy maximum of 2. It has increased from 2.14 (Mar 24) to 6.92, marking an increase of 4.78.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 111.40. This value is within the healthy range. It has decreased from 128.60 (Mar 24) to 111.40, marking a decrease of 17.20.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 51.80. This value is within the healthy range. It has decreased from 131.77 (Mar 24) to 51.80, marking a decrease of 79.97.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6.97. It has increased from 5.39 (Mar 24) to 6.97, marking an increase of 1.58.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 13.94. This value exceeds the healthy maximum of 3. It has increased from 4.77 (Mar 24) to 13.94, marking an increase of 9.17.
- For EV / EBITDA (X), as of Mar 25, the value is 125.12. This value exceeds the healthy maximum of 15. It has decreased from 181.40 (Mar 24) to 125.12, marking a decrease of 56.28.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 13.99. This value exceeds the healthy maximum of 3. It has increased from 4.78 (Mar 24) to 13.99, marking an increase of 9.21.
- For Price / BV (X), as of Mar 25, the value is 12.54. This value exceeds the healthy maximum of 3. It has increased from 10.14 (Mar 24) to 12.54, marking an increase of 2.40.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 13.99. This value exceeds the healthy maximum of 3. It has increased from 4.78 (Mar 24) to 13.99, marking an increase of 9.21.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Checkpoint Trends Ltd:
- Net Profit Margin: 5.08%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.58% (Industry Average ROCE: 16.29%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.55% (Industry Average ROE: 15.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 51.8
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 6.92
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 32.3 (Industry average Stock P/E: 47.27)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.08%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Pharmaceuticals | 604, 6th Floor, Meghdoot, Gulmohar Cross Road No. 6, Mumbai Maharashtra 400049 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sunil Khandalwal | Managing Director |
| Ms. Abha Kapoor | WholeTime Director & CFO |
| Mr. Pradeep Kumar | Whole Time Director |
| Mr. Shubham Chaudhary | Whole Time Director |
| Mr. Gopal Sahu | Ind. Non-Executive Director |
| Mr. Saurabh | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Checkpoint Trends Ltd?
Checkpoint Trends Ltd's intrinsic value (as of 29 January 2026) is ₹11.31 which is 90.73% lower the current market price of ₹122.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹66.5 Cr. market cap, FY2025-2026 high/low of ₹144/9.41, reserves of ₹-4 Cr, and liabilities of ₹141 Cr.
What is the Market Cap of Checkpoint Trends Ltd?
The Market Cap of Checkpoint Trends Ltd is 66.5 Cr..
What is the current Stock Price of Checkpoint Trends Ltd as on 29 January 2026?
The current stock price of Checkpoint Trends Ltd as on 29 January 2026 is ₹122.
What is the High / Low of Checkpoint Trends Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Checkpoint Trends Ltd stocks is ₹144/9.41.
What is the Stock P/E of Checkpoint Trends Ltd?
The Stock P/E of Checkpoint Trends Ltd is 32.3.
What is the Book Value of Checkpoint Trends Ltd?
The Book Value of Checkpoint Trends Ltd is 3.60.
What is the Dividend Yield of Checkpoint Trends Ltd?
The Dividend Yield of Checkpoint Trends Ltd is 0.00 %.
What is the ROCE of Checkpoint Trends Ltd?
The ROCE of Checkpoint Trends Ltd is 16.5 %.
What is the ROE of Checkpoint Trends Ltd?
The ROE of Checkpoint Trends Ltd is 9.17 %.
What is the Face Value of Checkpoint Trends Ltd?
The Face Value of Checkpoint Trends Ltd is 10.0.